1-4 of 4
Carolyn M. Mulroney
Close
Sort by
Journal Articles

A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and Tacrolimus

Divya Koura, James Mirocha, Kaitlyn C Dykes, Ayad Hamdan, Aaron Goodman, Tiffany N Tanaka, Carolyn M. Mulroney, Caitlin L. Costello, James K. Mangan, Edward D. Ball, Ah-Reum Jeong, Joseph Maroge, Michelle Padilla, Dimitrios Tzachanis
Journal: Blood
Blood (2023) 142 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2023-173906
Published: 2023
Journal Articles

Phase II Study of the Combination of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone (DIPD) As Salvage Therapy in Early Relapsed/Refractory Multiple Myeloma

Anupama Kumar, Aaron S. Rosenberg, Edward D. Ball, Sarah M. Larson, Lindsey Sirianni, Carolyn M. Mulroney, Caitlin L. Costello
Journal: Blood
Blood (2023) 142 (Supplement 1): 4750.
https://doi.org/10.1182/blood-2023-181091
Published: 2023
Journal Articles

A Phase I Trial of TGR-1202, a Next Generation Once-Daily PI3Kδ Inhibitor, in Combination with Brentuximab Vedotin, in Patients with Relapsed/Refractory Hodgkins Lymphoma

Radhakrishnan Ramchandren, MD, Carolyn M. Mulroney, MD, Manish R. Patel, MD, Peter Sportelli, Hari P. Miskin, MS, Robert W Chen, MD
Journal: Blood
Blood (2016) 128 (22): 4146.
https://doi.org/10.1182/blood.V128.22.4146.4146
Published: 2016
Journal Articles

Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies

Aaron M Goodman, MD, Michael Y. Choi, MD, Matthew J. Wieduwilt, MD PhD, Carolyn M. Mulroney, MD, Caitlin L Costello, MD, Razelle Kurzrock
Journal: Blood
Blood (2016) 128 (22): 5291.
https://doi.org/10.1182/blood.V128.22.5291.5291
Published: 2016